MK-677 for weight gain: separating real effects from TikTok hype
Quick answer
MK-677 (ibutamoren) is a ghrelin receptor agonist that stimulates endogenous growth hormone and IGF-1 secretion without exogenous GH administration. Clinical studies in elderly populations confirm increased lean mass and appetite, but also flag insulin resistance, peripheral edema, and elevated fasting glucose as recurring adverse effects. It remains an unapproved research compound with no established safety profile in young, healthy adults seeking body composition changes.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @s197.eduardo actually say?
Honestly, the video's audio is a song, not a voiceover. The actual claim lives entirely in the caption: "Was stuck at 130lbs for the longest time and ate so much. Just couldn't gain weight till i started doing Mk. Now currently at 160lbs." That's a 30-pound gain attributed directly to MK-677. He also self-identifies as "a rookie not professional," which matters.
There's no dosing information, no protocol, no timeline, and no mention of training changes or diet specifics beyond "ate so much." The claim is essentially: I was a hardgainer, I took MK-677, I gained weight. That's the whole argument. It's worth taking seriously, but it's also worth unpacking what that weight actually represents, because 30 pounds on a body is not all the same thing.
Does the science back this up?
MK-677 (ibutamoren) can absolutely cause weight gain. That part isn't disputed. The mechanism is real: it's a ghrelin receptor agonist that stimulates growth hormone and IGF-1 secretion. Studies confirm these effects. The question is what kind of weight gain and at what cost.
Svensson et al. (1998, Journal of Clinical Endocrinology and Metabolism) found that MK-677 increased lean body mass and GH secretion in healthy older adults. A longer 2-year trial by Nass et al. (2008, Journal of Clinical Endocrinology and Metabolism) confirmed GH and IGF-1 elevation but also flagged increases in fasting glucose and insulin resistance. Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism) showed it stimulated appetite significantly, which aligns with what Eduardo describes: eating more and finally gaining weight. So the biology checks out. But "weight gain" in MK-677 literature frequently includes water retention and increased appetite-driven caloric intake, not just lean muscle. A 30-pound gain with no body composition data is an incomplete story.
What did they get wrong (or right)?
Credit where it's due: he called himself a rookie, not a coach. That's more honest than most of these videos. And the experience he describes, an ectomorph struggling to eat enough who then gained weight after appetite stimulation, is pharmacologically plausible.
What's missing is context that matters. MK-677 reliably raises appetite and causes fluid retention. Some of that 30 pounds is almost certainly water. Without a DEXA scan or even before/after body fat estimates, "160lbs" tells you nothing about muscle versus fat versus water. Studies like Nass et al. (2008) also documented that roughly half of participants on long-term MK-677 experienced peripheral edema. Ghrelin receptor agonism also elevates cortisol transiently and can impair insulin sensitivity, which are not small side effects for someone whose baseline health metrics we know nothing about. The caption frames this as a simple win. The science says it's more complicated than that.
What should you actually know?
MK-677 is not approved by the FDA for any indication. It is not a SARM, though it is often grouped with them. It is a research compound. That means it's used off-label, the quality of unregulated sources varies dramatically, and long-term safety data in young, healthy adults is essentially nonexistent.
The short-term studies that do exist (mostly in elderly or growth hormone-deficient populations) show real physiological effects, but also consistent flags around blood glucose and insulin sensitivity. If you're a young person with family history of diabetes or pre-diabetes, those signals deserve serious attention. MK-677 also does not require injections, which makes it accessible, but accessibility is not the same as safety. Anyone considering it should do so under medical supervision with baseline labs including IGF-1, fasting glucose, and HbA1c. A 49,000-view TikTok caption is not a clinical protocol.
Bottom line
Eduardo's weight gain story is biologically plausible. MK-677 does stimulate GH, raises IGF-1, increases appetite, and can facilitate weight gain in people who struggle to eat enough. None of that is fabricated. But 30 pounds over an unspecified timeline with no body composition data, no labs, and no side effect disclosure is an incomplete picture. The science supports the mechanism. It does not support treating this caption as a template for your own protocol.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For MK-677 for weight gain: separating real effects from TikTok hype, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
MK-677 for weight gain: separating real effects from TikTok hype is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
MK-677 (ibutamoren) is a ghrelin receptor agonist that stimulates endogenous growth hormone and IGF-1 secretion without exogenous GH administration.
FormBlends verdict
MK-677 (ibutamoren) is a ghrelin receptor agonist that stimulates endogenous growth hormone and IGF-1 secretion without exogenous GH administration. Clinical studies in elderly populations confirm increased lean mass and appetite, but also flag insulin resistance, peripheral edema, and elevated fasting glucose as recurring adverse effects. It remains an unapproved research compound with no established safety profile in young, healthy adults seeking body composition changes.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- MK-677 (ibutamoren) is a ghrelin receptor agonist that stimulates endogenous growth hormone and IGF-1 secretion without exogenous GH administration. Clinical studies in elderly populations confirm increased lean mass and appetite, but also flag insulin resistance, peripheral edema, and elevated fasting glucose as recurring adverse effects. It remains an unapproved research compound with no established safety profile in young, healthy adults seeking body composition changes.
- MK-677 is a ghrelin receptor agonist, not a SARM. It stimulates your body's own GH and IGF-1 secretion rather than mimicking androgens.
- Murphy et al. (1998, JCEM) confirmed MK-677 significantly increases appetite, which can independently drive weight gain through higher caloric intake rather than direct anabolic effects.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- MK-677 is a ghrelin receptor agonist, not a SARM. It stimulates your body's own GH and IGF-1 secretion rather than mimicking androgens.
- Murphy et al. (1998, JCEM) confirmed MK-677 significantly increases appetite, which can independently drive weight gain through higher caloric intake rather than direct anabolic effects.
- Nass et al. (2008, JCEM) found that long-term MK-677 use caused peripheral edema in many participants, meaning a meaningful portion of scale weight gain may be fluid, not muscle.
- The same 2-year Nass et al. study flagged increases in fasting glucose and insulin resistance, risks that are absent from this creator's caption and most social media coverage.
- MK-677 has no FDA-approved indication. Existing clinical trials were conducted primarily in elderly or GH-deficient populations, not healthy young adults seeking body composition changes.
- A 30-pound weight change with no body composition testing, no timeline, and no side effect data cannot be evaluated as a success story. DEXA or at minimum skinfold measurements would be needed to interpret it meaningfully.
- Anyone considering MK-677 should get baseline IGF-1, fasting glucose, and HbA1c labs before starting and monitor them throughout. This is a compound with real physiological effects in both directions.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Eduardo · TikTok creator
49.6K views on this video
[I’m a rookie not professional] Was stuck at 130lbs for the longest time and ate so much Just couldn’t gain weight till i started doing Mk. Now currently at 160lbs #mk #mk677 #gym #stillskinny
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Eduardo, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.